IEC 2021 Symposium: A practical approach: Epilepsy misdiagnosis in clinical practice
View key takeaways from the IEC 2021 Symposium, sponsored by PTC Therapeutics, which discusses the differential diagnosis of aromatic L-amino acid decarboxylase (AADC) deficiency and how to recognize the red flag signs and symptoms in clinical practice
Recognize the challenges associated with differential diagnosis of neurotransmitter disorders, particularly those presenting with epileptic signs and symptoms, with a focus on AADC deficiency
Using a clinical case study, understand the red flags for AADC deficiency in clinical practice to aid early identification of this rare disease
Find out about the key role of carers and the importance of early diagnosis for families and caregivers of patients with AADC deficiency
This virtual symposium was developed and funded by PTC Therapeutics at the 2021 IEC Congress. It was not part of the official program of IEC 2021.
Register now to unlock the content
Register now to access the content on this page
If not, register below
MED-ALL-AADC-2200021 | March 2022
Sign in or register to access exclusive content on this site
Some cookies are essential, others help us improve your experience by providing insights into how the website is used. Select one or more of the cookie types listed below, and then save your preferences. Refer to our Cookies Statement for more information.
Performance cookies, which help us measure the website’s performance and improve your experience. In using performance cookies we do not store any personal data, and only use the information collected through these cookies in aggregated and anonymised form.